Jushi Holdings (JUSHF) Other Operating Expenses (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Other Operating Expenses of $1.5 million for Q2 2026, up 143.87% year-over-year from $615909.9 in Q2 2025, and down 94.69% quarter-over-quarter from $28.3 million in Q1 2026.
Jushi Holdings (JUSHF) Other Operating Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Other Operating Expenses for 6 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Operating Expenses rose 143.87% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $86.0 million (up 8.41% YoY), while the FY2024 annual figure was $432000.0, down 94.96% from the prior year.
- Other Operating Expenses eased to $1.5 million in Q2 2026 per JUSHF's latest filing, from $28.3 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $122.0 million in Q4 2022 and bottomed at -$3.4 million in Q2 2025.
- Historically, Other Operating Expenses has averaged $30.7 million across 5 years, with a median of $27.8 million in 2025.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 1823.79% — and 2025, when it tumbled 114.17%.
- Jushi Holdings' Other Operating Expenses stood at $122.0 million in 2022, then plunged by 92.97% to $8.6 million in 2023, then jumped by 217.8% to $27.2 million in 2024, then increased by 2.14% to $27.8 million in 2025, then slumped by 94.6% to $1.5 million in 2026.
- Business Quant data shows JUSHF's Other Operating Expenses at $1.5 million in Q2 2026, $28.3 million in Q1 2026, and $27.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 28.29 Mn |
| Dec 31, 2025 | 27.83 Mn |
| Sep 30, 2025 | 28.33 Mn |
| Jun 30, 2025 | -3.42 Mn |
| Mar 31, 2025 | 27.65 Mn |
| Dec 31, 2024 | 27.25 Mn |
| Sep 30, 2024 | 27.82 Mn |
| Jun 30, 2024 | 24.16 Mn |
| Mar 31, 2024 | 28.21 Mn |
| Dec 31, 2023 | 8.57 Mn |
| Jun 30, 2023 | 27.15 Mn |
| Mar 31, 2023 | 32.45 Mn |
| Dec 31, 2022 | 122.05 Mn |
| Sep 30, 2022 | 37.60 Mn |
| Jun 30, 2022 | 38.75 Mn |
| Mar 31, 2022 | 37.31 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Jun 30, 2021 | 26.36 Mn |